FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1485223239> ?p ?o ?g. }

• W1485223239 endingPage "679" @default.
• W1485223239 startingPage "667" @default.
• W1485223239 abstract "Factors regulating the citric acid cycle have been investigated in rat heart mitochondria oxidizing pyruvate plus malate or acetylcarnitine plus malate as substrates. Effects caused by changing the NAD oxidation-reduction state, the intramitochondrial ATP:ADP ratio, and the respiratory rate were studied in five different metabolic states produced by additions of ADP, oligomycin, or uncouplers. The accumulations of cycle intermediates and the mitochondrial content of CoA derivatives and pyridine nucleotides were measured in extracts prepared from the whole incubation medium or after rapid separation of the mitochondria from the medium. These data, together with measurements of substrate utilization, were used to calculate flux through the individual steps of the citric acid cycle. Pyruvate dehydrogenase was found not to be rate limiting for citric acid cycle activity. Flux through citrate synthase in State 3 was approximately the same (100 nmoles per min per mg) whether pyruvate or acetylcarnitine were used to generate acetyl-CoA, whereas acetyl-CoA levels were higher with pyruvate as substrate. Flux in State 4 with either substrate was diminished by 75 to 85% relative to State 3 and was associated during early incubation times with elevated levels of both NADH and acetyl-CoA, consonant with regulation of pyruvate dehydrogenase by product inhibition. A comparison of flux through citrate synthase and changes in the levels of intramitochondrial malate, citrate, ATP, and the NAD oxidation-reduction state showed that increased flux associated with a State 4 to 3 transition could be accounted for largely by an increased availability of oxalacetate to citrate synthase rather than by ATP inhibition. On the other hand, comparisons between states in which phosphate acceptor was not rate limiting for electron transport (State 3, uncoupled or uncoupled plus oligomycin) showed that oxalacetate availability remained high because of the highly oxidized state of the pyridine nucleotides, and indicated a regulation of citrate synthase under conditions of low acetyl-CoA availability by an energy-linked process dependent on substrate level phosphorylation. Thus, a 55% inhibition of flux through citrate synthase was obtained after addition of oligomycin to the uncoupled state with acetylcarnitine plus malate as substrate, but only a 25% inhibition was achieved with pyruvate plus malate as substrate. The intramitochondrial ATP:ADP ratio increased from 0.3 to 4:6 with either substrate under these conditions. A kinetic evaluation of the data indicated that the energy-dependent inhibition was not caused by a direct effect of ATP on citrate synthase, but was due to changes of the succinyl-CoA content relative to that of acetyl-CoA. This conclusion is based (a) on the finding of an accumulation of a short chain acyl-CoA compound identifiable as succinyl-CoA by direct enzyme assay under conditions of diminished citrate synthase flux, (b) a correlation between decreased flux and lowered acetyl-CoA levels in the different experiments, and (c) the observation that succinyl-CoA is an inhibitor of citrate synthase competitive with acetyl-CoA. A comparison of succinyl-CoA levels in mitochondria incubated in the different metabolic states indicated that its content was regulated by the phosphorylation state of the adenine nucleotides, presumably via the effect of altered GTP:GDP ratios on succinate thiokinase. Product inhibition of α-ketoglutarate dehydrogenase by succinyl-CoA was evidenced from an inverse relationship between α-ketoglutarate accumulation and succinyl-CoA levels. The conclusion is reached that feedback from the electron transport chain to the citric acid cycle is mediated by a combination of factors which include the phosphorylation state of the adenine and guanine nucleotides and the oxidation-reduction state of the pyridine nucleotides. Changes of these parameters secondarily affect the intramitochondrial concentrations of oxalacetate, acetyl-CoA, and succinyl-CoA, which are the direct regulators of citrate synthase activity." @default.
• W1485223239 created "2016-06-24" @default.
• W1485223239 creator A5001128846 @default.
• W1485223239 creator A5046594180 @default.
• W1485223239 creator A5068036628 @default.
• W1485223239 date "1972-02-01" @default.
• W1485223239 modified "2023-10-15" @default.
• W1485223239 title "Feedback Interactions in the Control of Citric Acid Cycle Activity in Rat Heart Mitochondria" @default.
• W1485223239 cites W100953422 @default.
• W1485223239 cites W107891412 @default.
• W1485223239 cites W1498088031 @default.
• W1485223239 cites W1506043065 @default.
• W1485223239 cites W1554239817 @default.
• W1485223239 cites W1561188729 @default.
• W1485223239 cites W1568560175 @default.
• W1485223239 cites W1576127155 @default.
• W1485223239 cites W1590222530 @default.
• W1485223239 cites W1594175305 @default.
• W1485223239 cites W1597903409 @default.
• W1485223239 cites W1607062550 @default.
• W1485223239 cites W164548000 @default.
• W1485223239 cites W1700958496 @default.
• W1485223239 cites W1803705701 @default.
• W1485223239 cites W1876969644 @default.
• W1485223239 cites W1974226019 @default.
• W1485223239 cites W1976810253 @default.
• W1485223239 cites W1988238572 @default.
• W1485223239 cites W1994401056 @default.
• W1485223239 cites W1995826493 @default.
• W1485223239 cites W1999793645 @default.
• W1485223239 cites W2005456813 @default.
• W1485223239 cites W2008341411 @default.
• W1485223239 cites W200998694 @default.
• W1485223239 cites W2020987912 @default.
• W1485223239 cites W2024049489 @default.
• W1485223239 cites W2024564250 @default.
• W1485223239 cites W2033732709 @default.
• W1485223239 cites W2038525816 @default.
• W1485223239 cites W2043040422 @default.
• W1485223239 cites W2052783498 @default.
• W1485223239 cites W2058882430 @default.
• W1485223239 cites W2060829865 @default.
• W1485223239 cites W2070375079 @default.
• W1485223239 cites W2073191691 @default.
• W1485223239 cites W2081830368 @default.
• W1485223239 cites W2082192551 @default.
• W1485223239 cites W2085639286 @default.
• W1485223239 cites W2094338942 @default.
• W1485223239 cites W2097237955 @default.
• W1485223239 cites W2117008455 @default.
• W1485223239 cites W2162020084 @default.
• W1485223239 cites W2162478262 @default.
• W1485223239 cites W2319953554 @default.
• W1485223239 cites W2428088027 @default.
• W1485223239 cites W3199747857 @default.
• W1485223239 doi "https://doi.org/10.1016/s0021-9258(19)45660-3" @default.
• W1485223239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/4333508" @default.
• W1485223239 hasPublicationYear "1972" @default.
• W1485223239 type Work @default.
• W1485223239 sameAs 1485223239 @default.
• W1485223239 citedByCount "164" @default.
• W1485223239 countsByYear W14852232392012 @default.
• W1485223239 countsByYear W14852232392013 @default.
• W1485223239 countsByYear W14852232392014 @default.
• W1485223239 countsByYear W14852232392015 @default.
• W1485223239 countsByYear W14852232392016 @default.
• W1485223239 countsByYear W14852232392017 @default.
• W1485223239 countsByYear W14852232392018 @default.
• W1485223239 countsByYear W14852232392019 @default.
• W1485223239 countsByYear W14852232392020 @default.
• W1485223239 countsByYear W14852232392021 @default.
• W1485223239 countsByYear W14852232392022 @default.
• W1485223239 countsByYear W14852232392023 @default.
• W1485223239 crossrefType "journal-article" @default.
• W1485223239 hasAuthorship W1485223239A5001128846 @default.
• W1485223239 hasAuthorship W1485223239A5046594180 @default.
• W1485223239 hasAuthorship W1485223239A5068036628 @default.
• W1485223239 hasBestOaLocation W14852232391 @default.
• W1485223239 hasConcept C154945302 @default.
• W1485223239 hasConcept C165135838 @default.
• W1485223239 hasConcept C185592680 @default.
• W1485223239 hasConcept C2775924081 @default.
• W1485223239 hasConcept C2779032678 @default.
• W1485223239 hasConcept C28859421 @default.
• W1485223239 hasConcept C41008148 @default.
• W1485223239 hasConcept C55493867 @default.
• W1485223239 hasConcept C62231903 @default.
• W1485223239 hasConcept C86803240 @default.
• W1485223239 hasConcept C95444343 @default.
• W1485223239 hasConceptScore W1485223239C154945302 @default.
• W1485223239 hasConceptScore W1485223239C165135838 @default.
• W1485223239 hasConceptScore W1485223239C185592680 @default.
• W1485223239 hasConceptScore W1485223239C2775924081 @default.
• W1485223239 hasConceptScore W1485223239C2779032678 @default.
• W1485223239 hasConceptScore W1485223239C28859421 @default.
• W1485223239 hasConceptScore W1485223239C41008148 @default.
• W1485223239 hasConceptScore W1485223239C55493867 @default.
• W1485223239 hasConceptScore W1485223239C62231903 @default.

• next